Acute Influenza Infection Presenting with Cardiac Tamponade: A Case Report and Review of Literature

Abstract

1829 patients underwent radical prostatectomy with pelvic lymph node dissection (RP+PLND) (241 high-risk, 943 intermediate-risk, 645 low-risk). Positive margin rates were 17.8%, 14.8%, and 11.9% in the high, intermediate-and lowrisk groups. Five-year overall survival was 92.5% in lymph node-positive patients and 94.9% in lymph node-negative patients (p = 0.8). Age, prebiopsy prostatespecific antigen, and clinical stage were associated with positive surgical margins in patients with lymph node metastasis (LNM). Recipients of RP+PLND with LNM and positive surgical margins required adjuvant treatment.

Cardiac Tamponade Secondary to Influenza B Infection

“…Additionally, Influenza B only accounts for approximately 0.08% of circulatory and/or respiratory-related hospitalizations [14]. In most reported cases of severe pericarditis or cardiac tamponade secondary to Influenza, it is Influenza A that is implicated [15][16][17].…”

Zagrażające życiu zapalenie osierdzia i opłucnej spowodowane przez grypę B i skutecznie wyleczone podczas pandemii COVID-19

“…Only few cases of pericarditis (without myocardial involvement) were reported, but in "high risk" patients with co--morbidities, during: InfA (first case: hypertension, nicotinism; pericardiocentesis 250 mL, ibuprofen, colchicum, oseltamivir [2]; second case: alcohol, cocaine; pericardiocentesis, antibiotic, oseltamivir, nonsteroidal anti-inflammatory drugs (NSAIDs), colchicum [5]) and InfB (21 trisomy, ASD; ibuprofen, colchicum, oseltamivir, steroids, furosemide) [1].…”

“…Influenza causes 300,000 deaths per year in the world [1]. Although the respiratory system is commonly affected, cardiac involvement also occurs (direct virus impact on heart or preexisting cardiovascular disease exacerbation) [2]. In 2020, World Health Organization (WHO) declared SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection (COVID-19, coronavirus disease 2019) a pandemic.…”

Reincidencia de eventos coronarios: disfunción endotelial como mediadora

“…La dobutamina reduce la resistencia sistémica, lo que aumenta la FEVI y la FC, así como la perfusión cardíaca (14,15) . El suero intravenoso y los vasopresores pueden ser utilizados para lograr la estabilización hemodinámica (16) .…”